Site Search Investor Relations Omnicell is transforming the pharmacy care delivery model, dramatically improving outcomes and lowering costs through a combination of automation, intelligence, and technology-enabled services powered by a cloud data platform designed to empower pharmacists and clinicians to focus on patient care. Slide 1 Slide 2 Slide 3 showing slide 1 of 3 NASDAQ: OMCL176.65-0.35 (-0.20%) 20 minutes minimum delay | December 1, 2021 3:29 PM Events & Presentations UPCOMING | December 3, 2021 | 10:00 AM CT 2021 Stephens Investment Conference Add to Calendar Webcast (opens in new window) PAST | December 1, 2021 | 09:00 AM EST Piper Sandler 33rd Annual Healthcare Conference Webcast (opens in new window) All Events November 2, 2021 Investor Presentation - November 2021 Download PDF (opens in new window) All Presentations July 26, 2021 Omnicell to Acquire FDS Amplicare Download PDF (opens in new window) All Presentations Recent Releases showing 1-2 of 3 November 22, 2021 Omnicell to Present at Upcoming Investor Conferences Read More November 10, 2021 Omnicell and Fresenius Kabi Collaborate to Enhance Management of Controlled Substances in U.S. Hospitals Read More Slide 1 Slide 2 Slide 3 All Releases Quarterly Earnings Press Release Earnings Call (opens in new window) Complementary Summary (opens in new window) Form 10-Q (opens in new window) Q3 2021 All Quarterly Results Investor Resources Investor Contact Kathleen Nemeth Vice President, Investor Relations ir@omnicell.com Quick Links Stock Price SEC Filings Annual Reports Investor Alerts Email Address News Events & Presentations Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote Unsubscribe Submit Careers Contact Us Support myOmnicell For Health System For Hospital For Retail Pharmacy For Closed Door Pharmacy For Pharmacists For Nursing For Physicians For IT Management Facebook Twitter Linkedin Privacy Notice Terms Legal Notices HIPAA Statement Anti-Trafficking